| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 47 |
| 1 | CARBOPLATIN | 44 |
| 2 | PACLITAXEL | 36 |
| 3 | PEMETREXED DISODIUM | 26 |
| 4 | GEMCITABINE HYDROCHLORIDE | 25 |
| 5 | ACETAMINOPHEN | 21 |
| 6 | MEROPENEM | 21 |
| 7 | CISPLATIN | 20 |
| 8 | DEXAMETHASONE | 20 |
| 9 | DEXAMETHASONE 1.5 MG | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 1 | 0.0204 |
| 1 | EPCORITAMAB-BYSP | 13 | 0.0097 |
| 2 | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | 1 | 0.0025 |
| 3 | DIAZOXIDE | 1 | 0.0014 |
| 4 | ENFORTUMAB VEDOTIN | 10 | 0.0013 |
| 5 | TALIMOGENE LAHERPAREPVEC | 2 | 0.0013 |
| 6 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 3 | 0.0012 |
| 7 | DAUNORUBICIN HYDROCHLORIDE | 2 | 0.0012 |
| 8 | CEMIPLIMAB-RWLC | 2 | 0.0010 |
| 9 | LETERMOVIR | 3 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 14 | 0.0035 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 143 | 0.0015 |
| 3 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 3 | 0.0009 |
| 5 | Osmotic Diuretic [EPC] | 4 | 0.0008 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 7 | Penem Antibacterial [EPC] | 21 | 0.0006 |
| 8 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |